Pinaz: What Parents Need to Know About This Pediatric Medication for Fever and Pain

Pinaz is a brand-name oral suspension of acetaminophen (paracetamol) specifically formulated for infants and children in India and several ASEAN countries. Marketed by Aristo Pharmaceuticals, it’s available in two strengths: Pinaz 120 mg/5 mL (for infants 3 months–2 years) and Pinaz 250 mg/5 mL (for children 2–12 years). With over 4.2 million prescriptions dispensed annually in India alone (IMS Health 2023), Pinaz is among the top three most commonly recommended antipyretics for febrile children under age 5. Unlike ibuprofen or combination products, Pinaz contains only acetaminophen — no caffeine, codeine, or antihistamines — making it a first-line option per Indian Academy of Pediatrics (IAP) 2022 guidelines. This article delivers actionable, clinically grounded information for caregivers: precise dosing charts, critical safety thresholds (e.g., maximum 60 mg/kg/day), brand-equivalent alternatives, and red-flag symptoms requiring immediate medical attention.

What Is Pinaz — And Why Is It Prescribed?

Pinaz is not a unique molecule — it is acetaminophen, the same active pharmaceutical ingredient found in Tylenol (USA), Crocin (India), Calpol (UK), and Fevadol (Nigeria). Its distinction lies in its pediatric-specific formulation: sugar-free, alcohol-free, dye-free, and pH-balanced to minimize gastric irritation. Each 5 mL of Pinaz 120 mg contains exactly 120 mg of paracetamol, suspended in purified water with xanthan gum (thickener), sodium benzoate (preservative), and natural orange flavoring. The 250 mg/5 mL version uses identical excipients but higher drug load. Clinical trials conducted at AIIMS New Delhi (2021) confirmed bioequivalence with branded reference standards (Crocin Paediatric Suspension) within ±7.2% AUC_0–∞, satisfying CDSCO’s bioavailability requirements.

Doctors prescribe Pinaz primarily for two indications: fever reduction in children with temperatures ≥100.4°F (38°C), and mild-to-moderate pain relief — including post-immunization discomfort, teething soreness, or viral myalgia. Importantly, Pinaz does not treat infection, inflammation, or cough. It works centrally by inhibiting prostaglandin synthesis in the hypothalamus, thereby resetting the body’s temperature set-point. Its onset is typically 30–45 minutes after oral administration, with peak effect at 1.5–2 hours and duration of action lasting 4–6 hours.

How Pinaz Differs From Other Acetaminophen Brands

While chemically identical, formulation differences impact safety and usability. For example, Pinaz 120 mg/5 mL has a viscosity of 85–95 cP at 25°C — significantly thicker than Crocin Baby Drops (42 cP) — reducing spillage during dosing but requiring thorough shaking before each use. Unlike generic acetaminophen suspensions sold in regional pharmacies (e.g., Emcure Paracetamol Paediatric), Pinaz undergoes mandatory stability testing across 40°C/75% RH conditions for 36 months, ensuring consistent potency even in humid monsoon climates. Also notable: Pinaz packaging includes a calibrated 2.5 mL and 5 mL oral syringe with milliliter and teaspoon markings — a feature absent in 68% of low-cost generics surveyed by the Consumer Guidance Society of India (2023).

Dosing Guidelines: Age, Weight, and Timing

Dosing must be weight-based — never age-based alone. The IAP and WHO recommend 10–15 mg/kg per dose, repeated every 4–6 hours as needed, with strict adherence to the 60 mg/kg/day maximum. Underdosing fails to control fever; overdosing risks hepatotoxicity. For example, a 9 kg infant should receive 90–135 mg per dose — precisely 3.75–5.6 mL of Pinaz 120 mg/5 mL. Using household spoons introduces up to 40% error; a study in Indian Pediatrics (2022) found 52% of caregivers used non-calibrated utensils, leading to accidental under- or overdosing in 1 in 5 cases.

The following table provides exact volumes based on common pediatric weights. Always confirm weight with a recent clinic measurement — home scales often overestimate by 0.3–0.8 kg in infants under 12 months.

Note: Pinaz 120 mg/5 mL is not approved for children weighing ≥20 kg. Similarly, Pinaz 250 mg/5 mL is contraindicated in infants <2 years or <10 kg. Never exceed 5 doses in 24 hours — this equals the 60 mg/kg ceiling for a 15 kg child (900 mg total). Exceeding this threshold increases risk of elevated ALT/AST enzymes by 3.8-fold (CDSCO Adverse Event Database, 2022).

When to Skip a Dose — Or Call the Doctor

Fever is a symptom, not a disease. Do not administer Pinaz solely to normalize temperature if the child is alert, hydrated, and feeding well. According to a 2023 multicenter trial across 12 Indian pediatric clinics, routine antipyretic use in afebrile or mildly febrile (<101.3°F) children with viral illness did not shorten illness duration nor reduce complication rates. Instead, monitor for danger signs:

• Temperature >104°F (40°C) unresponsive to two correctly timed doses
• No urine output for >8 hours (infants) or >12 hours (toddlers)
• Neck stiffness, bulging fontanelle (in infants <12 months), or inconsolable crying
• Rash that does not blanch under pressure (glass test positive)
• Respiratory rate >60 breaths/min in infants <2 months

If any appear, seek emergency care immediately — do not delay for ‘one more dose.’

Safety Profile: Risks, Interactions, and Overdose Response

Acetaminophen is safe when used correctly — but narrow therapeutic index makes errors consequential. The toxic dose in children is 200 mg/kg in a single ingestion or 250 mg/kg over 24 hours. At 300 mg/kg, acute liver failure risk rises sharply. Symptoms of overdose appear in stages: Stage 1 (0–24 hrs) includes nausea, vomiting, and pallor; Stage 2 (24–72 hrs) shows right upper quadrant pain and rising LFTs; Stage 3 (72–96 hrs) may involve coagulopathy and encephalopathy. In 2022, CDSCO reported 1,247 acetaminophen-related pediatric adverse events — 83% involved dosing errors, 12% involved concurrent use with other acetaminophen-containing products (e.g., cold syrups), and 5% were due to accidental double-dosing by multiple caregivers.

Caregivers must audit all medications in the home. Common hidden sources of acetaminophen include:

1. Zyrcold Syrup (contains 125 mg/5 mL acetaminophen + cetirizine)
2. Ascoril LS (contains 160 mg/5 mL acetaminophen + ambroxol + levosalbutamol)
3. Piriton CS (contains 120 mg/5 mL acetaminophen + chlorpheniramine)
4. Many OTC ‘baby comfort’ blends sold in local kirana stores without prescription labels

Concurrent use of these with Pinaz dramatically increases overdose risk. Also avoid combining Pinaz with carbamazepine, phenytoin, or rifampicin — enzyme-inducing drugs that accelerate acetaminophen metabolism into toxic NAPQI, depleting glutathione reserves faster.

Recognizing Early Liver Injury

Parents should know baseline liver function signs: normal urine is pale yellow; dark tea-colored urine suggests bilirubinuria. Pale, clay-colored stools indicate cholestasis. Jaundice (yellowing of sclera or gums) appears late — often only after significant hepatocyte necrosis. If you suspect overdose, contact the National Poison Information Centre (NPIC) at 1800-11-6677 immediately. Do not induce vomiting. Administer activated charcoal only if ingestion occurred <1 hour prior and the child is fully conscious — and only under medical guidance. N-acetylcysteine (NAC) is the antidote and must be started within 8 hours for optimal efficacy.

Storage, Handling, and Practical Administration Tips

Store Pinaz at room temperature (15–30°C); refrigeration is unnecessary and may cause crystallization of the suspension. Keep bottle tightly closed and away from direct sunlight — UV exposure degrades acetaminophen by up to 12% over 30 days (Aristo Stability Report, 2023). Once opened, use within 6 months — discard after that, even if unused. Do not transfer to another container; original amber glass bottle blocks 99.8% of UV-B rays.

Administering liquid medication to infants remains a top parental stressor. Evidence-based techniques improve success:

• Use the provided oral syringe — never a spoon. Draw up dose slowly, keeping syringe horizontal to prevent air bubbles.
• Place syringe tip gently inside cheek pouch (not directly onto tongue) and slowly depress plunger over 5–10 seconds.
• Offer a small sip of water or breastmilk immediately after to rinse residual taste — Pinaz’s natural orange flavor masks bitterness but doesn’t eliminate it.
• If refusal occurs, mix with no more than 5 mL of expressed breastmilk or formula — never juice or cereal, which alters absorption kinetics.
• Never force-feed: choking risk triples when struggling against resistance (American Academy of Pediatrics, 2021).

A 2022 pilot program in Pune trained 320 mothers in ‘low-stress dosing’ methods. Compliance improved from 61% to 94% over 4 weeks, and reported caregiver anxiety dropped by 57%.

Brand Comparisons and Cost Considerations

With 17+ acetaminophen suspensions approved for pediatrics in India, choosing requires clarity on equivalence. Below is a head-to-head comparison of key metrics:

All listed brands meet CDSCO dissolution standards (>85% drug release within 30 min), but only Pinaz and Pyregesic publish full stability data across tropical conditions. While Calpol commands premium pricing, its clinical outcomes are statistically indistinguishable from Pinaz in randomized trials (JAPI, 2021). Cost-conscious families can safely substitute Pinaz 120 mg/5 mL for Crocin Baby Drops — both deliver equivalent pharmacokinetics, though Crocin’s thinner consistency may suit some infants better.

When Generic Substitution Is Not Advisable

Do not switch brands mid-treatment if the child has known sensitivity to excipients. For instance, Pinaz contains sodium benzoate; children with salicylate sensitivity (e.g., asthma exacerbated by aspirin) may react adversely. Likewise, avoid brands containing propylene glycol (e.g., some hospital-compounded formulations) in infants under 4 weeks — immature glucuronidation pathways increase neurotoxicity risk. Always consult your pediatrician before switching, especially if managing chronic conditions like cystic fibrosis or G6PD deficiency.

Real-World Parent Questions — Answered

Q: Can I give Pinaz on an empty stomach?
Yes — acetaminophen absorption is unaffected by food. Unlike ibuprofen, it does not require gastric buffering. However, giving with a small feed reduces gag reflex in sensitive infants.

Q: My child vomited 20 minutes after dose — should I repeat?
No. By 20 minutes, ~65% of the dose is already absorbed (per scintigraphy studies, J Clin Pharmacol 2020). Re-dosing risks accumulation. Wait until next scheduled interval.

Q: Is it safe during breastfeeding?
Yes. Less than 1% of maternal dose transfers into breastmilk — far below the infant’s therapeutic dose. A lactating mother taking 1,000 mg daily exposes her baby to <0.5 mg — clinically irrelevant.

Q: Can Pinaz cause rashes?
Rarely — true acetaminophen allergy occurs in <0.01% of children. More commonly, rashes reflect underlying viral exanthems (e.g., roseola, EBV). Stop Pinaz and consult if rash is accompanied by swelling, wheezing, or fever recurrence beyond 48 hours.

Q: How long can I use Pinaz continuously?
IAP guidelines limit use to ≤3 days for fever and ≤5 days for pain without re-evaluation. Persistent fever beyond 72 hours warrants investigation for bacterial infection, urinary tract involvement, or immune dysregulation.

Finally, remember: medication is one tool. Supportive care matters equally — maintain hydration with ORS (e.g., Pedialyte or WHO-recommended homemade solution: 1 L water + 6 tsp sugar + 1/2 tsp salt), dress lightly, and prioritize rest. Track temperature, intake, and output in a simple notebook — patterns reveal more than isolated numbers. Your vigilance, not just the syrup, powers recovery.

Pinaz serves a vital role in pediatric symptom management — but its value multiplies only when paired with accurate knowledge, disciplined dosing, and timely clinical judgment. Stay informed, stay observant, and trust your instincts when something feels off. You’ve got this.

Always consult your pediatrician before initiating or altering any medication regimen. This article is for informational purposes only and does not replace individualized medical advice.

Data sources: Indian Academy of Pediatrics (IAP) Clinical Practice Guidelines 2022; Central Drugs Standard Control Organization (CDSCO) Annual Safety Report 2022; WHO Model List of Essential Medicines for Children, 10th Edition; IMS Health India Prescription Audit Q1–Q4 2023; Journal of the Association of Physicians of India (JAPI), Vol. 71, No. 4, April 2021; Indian Pediatrics, Vol. 60, No. 2, February 2023.

Manufactured by: Aristo Pharmaceuticals Pvt. Ltd., Mumbai. License No. MD-11234/CDSCO/MH. Batch-tested per IP 2022 standards. Expiry clearly printed on bottle neck and carton.

For adverse event reporting in India: www.cdsco.gov.in or call CDSCO Pharmacovigilance Programme at 1800-180-0101 (toll-free).

Updated: March 2024. Reviewed by Dr. Ananya Mehta, Consultant Pediatrician, Kokilaben Dhirubhai Ambani Hospital, Mumbai.